This content is from: Research
The 2013 All-America Research Team: Managed Care, No. 2: Joshua Raskin
Barclays’s Joshua Raskin slips to second place; he also captures a runner-up position in Health Care Facilities.
Barclays’s Joshua Raskin slips to second place; he also captures a runner-up position in Health Care Facilities. “Josh knows the HMOs like the back of his hand,” praises one investor. “Nobody on the Street is better at distilling complex information into digestible data points.” Raskin has maintained a bullish stance on the sector. In January he forecast share gains for the largest and most efficient managed care providers, updating target prices for stocks under his coverage universe accordingly. “We are specifically more constructive on the Medicare segment and continue to see very strong long-term value in Medicaid,” he noted. At the same time, Raskin upgraded Humana from equal weight to outperform, at $67.47, deeming the Louisville, Kentucky–based administrator best positioned to benefit from growth in the Medicare Advantage program and predicting that Humana will grow at rates that surpass industry averages. Humana’s stock had leaped 36.5 percent by the end of August, surpassing the sector by 9.7 percentage points. “Josh has extensive experience following the sector and understands the nuances of the managed care industry,” chimes another proponent. “He is very good at asking managements insightful questions that often address the key issues on everyone’s mind.” — Leslie Kramer